Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy
作者单位：Departments of Pathology, Military Institute of Medicine, Warsaw, Poland[1]Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland[2]Department of Gynecology and Gynecologic Oncology, Military Institute of Medicine, Warsaw, Poland[3]
换一批
